Stimulates synoviocyte production of lubricin and hyaluronic acid. Inhibits cartilage-degrading enzymes (aggrecanase, MMP-3). Anti-inflammatory in synovial tissue. Mild anticoagulant effects (structural similarity to heparin). Bladder glycosaminoglycan layer restoration in IC.
Studies have administered: 100mg three times daily oral (approved IC dose); 1–3mg/kg IA injection in joint research
FDA-approved for interstitial cystitis (oral). Joint injection phase 2: cartilage protection and symptom reduction in OA. Equine veterinary research extensive. Human OA trials ongoing in Australia.
Pigmentary maculopathy risk with long-term high-dose oral use (important monitoring consideration); anticoagulant effects at high dose
These compounds have been examined together in research literature. Combination use is not endorsed or recommended — this information is provided for research context only.
Want a Complete Research Monograph?
Our AI can generate a 2,000+ word deep-dive on Pentosan Polysulfate (PPS) — including full clinical trial summaries, pharmacokinetics, and research frontiers.
Generate Deep Dive in Research Chat